Glenn Tillotson

17PUBLICATIONS
10CO-AUTHORS
Infectious diseasesPublic health nutritionMedical bacteriologyMedical infection agents (incl. prions)Mortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Dec 25, 2025
Epidemiology, length of stay, and survival outcomes of Candida auris infections in a tertiary care center in the greater detroit area.

Hussein Tehaili, Shayan Sharifi, Sruti Ramamoorthy

|Sep 14, 2024
The 3 Ds: Depression, Dysbiosis, and Clostridiodes difficile.

Antoine Boustany, Paul Feuerstadt, Glenn Tillotson

|May 27, 2024
Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone.

Herbert L DuPont, Andrew W DuPont, Glenn S Tillotson

|Feb 20, 2024
Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details.

Lea Monday, Glenn Tillotson, Teena Chopra

|Sep 05, 2023
Patient Perception of Route of Rectal Administration of Live Biotherapeutic Product for Recurrent Clostridioides difficile Infection.

Paul Feuerstadt, Caterina Oneto, Glenn Tillotson

|Mar 07, 2023
The burden of CDI in the United States: a multifactorial challenge.

Paul Feuerstadt, Nicolette Theriault, Glenn Tillotson

Pageof 3